Pitavastatin (calcium salt)

DESCRIPTION

An HMG-CoA reductase inhibitor (Ki = 1.7 nM for the rat liver microsomal enzyme); inhibits sterol biosynthesis in rat liver and ileum (ED50s = 0.13 and 0.2 mg/kg, respectively); reduces plasma levels of triglycerides and total cholesterol in dogs; increases survival in Dahl salt-sensitive rats fed a high-salt diet at 0.3 mg/kg

DETAILS

Inchi: InChI=1S/C25H24FNO4.Ca/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;+2/p-1/b12-11+;/t18-,19-;/m1./s1
Purity: ≥98%
Raptas: Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias
Smiles: [O-]C(C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)=O.[Ca+2]
Inchikey: VSQHXQMFUCHGBD-NRFPMOEYSA-M
Cas Number: 147526-32-7
Formulation: A crystalline solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C25H23FNO4 •1/2Ca
Formula Weight: 440.5
Shelf Life Days: 1460

This item requires additional questions and potential approval.